Type 1 diabetes mellitus and endometriosis separately affect millions of women worldwide. Reproductive-age women diagnosed with type 1 diabetes may also suffer from endometriosis, but the asymptomatic pre-clinical period of highly variable duration for each condition can lead to challenges in the timely recognition of co-morbid disease onset and misdiagnosis. While knowledge of the pathogenesis of each condition has grown substantially, co-morbid endometriosis and type 1 diabetes has not been widely considered and much less addressed. This review discusses the molecular rationale for the likelihood of their co-existence, and prospects for improvements in therapeutic strategies and reduced complications, if this paradigm is included as a significant variable in disease management.
Co-morbidity of type 1 diabetes and endometriosis: bringing a new paradigm into focus.
R. Simmen,Dustin M Brown,C. Quick,Iad Alhallak,Tyler Rose,Shi J. Liu,A. S. Kelley
Published 2019 in Journal of Endocrinology
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
Journal of Endocrinology
- Publication date
2019-08-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-7 of 7 citing papers · Page 1 of 1